Donor‐specific transfusion via the portal venous route induces prolongation of H‐2‐compatible but not H‐2‐incompatible cardiac graft survival

D. Górecki, M. Jakóbisiak, M. Lupińska, A. Kruszewski, J. Czyńyk

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Abstract. In the H‐2‐compatible donor‐recipient combination (BALB/c ± DBA/2), pretransplant donor‐specific blood transfusion (DST) via the portal venous (PV) route significantly prolonged cardiac graft survival. DST via the intravenous (IV) route (systemic circulation) also showed a marked prolongation of heart tissue transplant survival in this model. In the H‐2‐incompatible combination (BALB/c → CBA/H), DST via the IV ‐ but not via the PV ‐ route resulted in accelerated graft rejection.

Original languageEnglish (US)
Pages (from-to)199-202
Number of pages4
JournalTransplant International
Volume2
Issue number1
DOIs
StatePublished - Jan 1989
Externally publishedYes

Keywords

  • Transfusion effect
  • experimental
  • experimental ‐ Portal venous route
  • heart ‐ Heart transplantation
  • intraportal route ‐ Transfusion effect
  • transfusion effect

Fingerprint Dive into the research topics of 'Donor‐specific transfusion via the portal venous route induces prolongation of H‐2‐compatible but not H‐2‐incompatible cardiac graft survival'. Together they form a unique fingerprint.

Cite this